StageZero Life Sciences Ltd. SZLSF
0.00 USD 0.00 (+0.00%)
Regular-session close
0.0117 Day range 0.0117
0.0005 52-week range 0.0117
- YTD
- +100.00%
- 1 year
- -80.39%
News
defenseworld.net Financial Survey: Stagezero Life Sciences (OTCMKTS:SZLSF) and Envista (NYSE:NVST) Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Envista (NYSE: NVST - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies…
defenseworld.net Fonar (NASDAQ:FONR) and Stagezero Life Sciences (OTCMKTS:SZLSF) Head-To-Head Comparison Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Fonar (NASDAQ: FONR - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two…
defenseworld.net Head-To-Head Review: Insulet (NASDAQ:PODD) and Stagezero Life Sciences (OTCMKTS:SZLSF) Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Insulet (NASDAQ: PODD - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies…
defenseworld.net Contrasting Stagezero Life Sciences (OTCMKTS:SZLSF) and TriSalus Life Sciences (NASDAQ:TLSI) Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and TriSalus Life Sciences (NASDAQ: TLSI - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will…
thenewswire.com StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer TORONTO, ON - TheNewswire - May 13, 202 5 - StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), and ElevationMD ( “ElevationMD”) today announced the introduction…
accesswire.com StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene…
accesswire.com StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene…
seekingalpha.com StageZero Life Sciences Ltd. (SZLSF) Q1 2024 Earnings Call Transcript StageZero Life Sciences Ltd. (OTCQB:SZLSF) Q1 2024 Results Conference Call May 21, 2024 8:00 AM ET Company Participants Rebecca Greco - Head Investor Relations James Howard Tripp - Chairman & Chief…
accesswire.com StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for…
accesswire.com StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA…
accesswire.com StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA…
accesswire.com StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic…
accesswire.com StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA Aristotle and AVRT to be offered to My One Medical Source's Customer Base TORONTO, ON / ACCESSWIRE / November 14, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the…
accesswire.com StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patients TORONTO, ON / ACCESSWIRE / November 7, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF)…
accesswire.com StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings CareOncology partners with The Source Functional Nutrition to offer nutritional guidance to cancer patients. TORONTO, ON / ACCESSWIRE / October 20, 2023 / StageZero Life Sciences, Ltd.
newsfilecorp.com StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special…
newsfilecorp.com StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30 Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022…
seekingalpha.com StageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call Transcript StageZero Life Sciences Ltd. (OTCQB:SZLSF) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants Rebecca Greco - Head, Investor Relations James R.
seekingalpha.com StageZero Life Sciences Ltd. (SZLSF) CEO James Howard-Tripp on Q2 2022 Results - Earnings Call Transcript StageZero Life Sciences Ltd. (OTCQB:SZLSF) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Rebecca Greco - Head, Investor Relations James Howard-Tripp - Chairman &…
accesswire.com StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting TORONTO, ON / ACCESSWIRE / June 28, 2022 / StageZero Life Sciences, Ltd (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all of the…
